New Drivers for Change in Biopharma Manufacturing

In recent years, the speed by which the biopharma industry is expected to research, manufacture and supply new medicines to patients has significantly increased. In correlation, digital technology adoption has accelerated, creating significant challenges and opportunities. To remain competitive, manufacturers have had to adapt quickly and focus on driving technology innovations to meet speed to market requirements.

‘Digital technologies are essential; they are no longer a nice to have. You need to deploy these technologies to stay competitive and ensure patients are receiving treatments.'
Matt Moran, Director, BioPharmaChem Ireland

In this special discussion programme, biopharma industry leaders discuss how this paradigm shift impacts manufacturers, the supply chain, the patient and the workforce, revealing key insights including:

• New trends shaping the biopharma industry today
• Digitalization and IT/OT convergence
• Emerging technologies and supply chain efficiencies
• Next generation of therapeutics and the future of biopharma
• Workforce implications for STEM graduates and the hiring environment